Applied Therapeutics Inc (APLT)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -260.621 | -140.413 | -132.623 | -122.909 | -108.627 | -128.662 | -257.013 |
Return on Equity (%) | 216.208 | 140.288 | -699.393 | -164.058 | -146.159 | -247.772 | 1830.539 |
Return on Invested Capital (%) | -373.746 | -149.279 | -189.035 | -165.518 | -146.613 | -248.852 | 1006.865 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | -1198.469 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | -1198.469 |
Book Value Per Share | 0.268 | 1.838 | 1.251 | 3.143 | 1.853 | 0.073 | -0.202 |
Earnings Per Share | -0.501 | -1.919 | -1.746 | -3.604 | -3.128 | -1.484 | -1.413 |
Cash Per Share | 0.383 | 2.178 | 0.723 | 2.204 | 1.596 | 0.3 | 0.589 |
Working Capital Per Share | 0.268 | 1.838 | 1.23 | 3.121 | 1.835 | 0.07 | -0.198 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | 0.118 |
EBIT Per Share | -0.501 | -1.919 | -1.746 | -3.604 | -3.128 | -1.484 | -1.413 |
EBITDA Per Share | -0.501 | -1.919 | -1.746 | -3.604 | -3.128 | -1.484 | -1.413 |
Free Cash Flow Per Share | -0.501 | -1.919 | -1.746 | -3.604 | -3.128 | -1.484 | -1.413 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 5,46M | 5,51M | 18,53M | 18,53M | 26,22M | 48,06M | N/A |
Fin d'année 31 Décembre 2023 | Juin 2022 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | N/A | 48,06M | 48,06M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | -95.094 | N/A | N/A | N/A | -44177.895 |
Net Profit Margin (%) | N/A | N/A | N/A | -95.094 | N/A | N/A | N/A | -44177.895 |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,01B |
Ratio cours/bénéfice | -8,4 |
Ratio prix/ventes | 100,7 |
Ratio prix/liquidités | 20,17 |
Ratio prix/valeur comptable | -58,7 |
Rendement de dividende | - |
Actions en circulation | 116,36M |
Volume moyen (1 semaine) | 2,18M |
Volume moyen (1 mois) | 1,82M |
Variation sur 52 semaines | 348,19% |
Plus haut sur 52 semaines | 10,6237 |
Plus bas sur 52 semaines | 1,79 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales